Graves

n.

（法国）格拉夫葡萄酒；

graves disease格氏病；格雷夫斯病

Management of Graves' ophthalmopathy: reality and perspectives
Graves' Ophthalmopathy: Current Concepts Regarding Pathogenesis and Management*
CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
Modification of the classification of the eye changes of Graves' disease.
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.